Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of the Efficacy and Safety of Tocilizumab for Treatment of Inflammation in the Renal Allograft

NCT02108600 is registered in ClinicalTrials.gov with Flavio Vincenti as lead sponsor.

NCT NCT02108600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02108600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of the Efficacy and Safety of Tocilizumab for Treatment of Inflammation in the Renal Allograft
Lead sponsor
Flavio Vincenti
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2014
Completion date
December 16, 2018
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

late complication from kidney transplant